Compare HUYA & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HUYA | OFIX |
|---|---|---|
| Founded | 2014 | 1987 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 694.8M | 622.1M |
| IPO Year | 2018 | N/A |
| Metric | HUYA | OFIX |
|---|---|---|
| Price | $3.71 | $14.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $3.50 | ★ $21.50 |
| AVG Volume (30 Days) | ★ 1.4M | 207.0K |
| Earning Date | 11-12-2025 | 02-24-2026 |
| Dividend Yield | ★ 71.35% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $879,277,448.00 | $818,058,000.00 |
| Revenue This Year | $9.05 | $3.97 |
| Revenue Next Year | $11.33 | $5.84 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 2.40 | ★ 4.31 |
| 52 Week Low | $2.21 | $10.24 |
| 52 Week High | $4.59 | $20.48 |
| Indicator | HUYA | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | 67.54 | 36.82 |
| Support Level | $3.43 | $14.72 |
| Resistance Level | $3.93 | $16.42 |
| Average True Range (ATR) | 0.20 | 0.58 |
| MACD | 0.07 | -0.09 |
| Stochastic Oscillator | 80.09 | 8.85 |
Huya, officially became independent in 2016 and headquartered in Guangzhou, operates live streaming platform focused on games, esports, and interactive entertainment, and also provides game-related services such as distribution and in-game item sales. Its main livestreaming platforms include Huya Live in China and Nimo TV outside of China. As of 2024, Huya was a subsidiary of Tencent, which owned 67% of its equity stake and held 95% of the voting power.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.